Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer

Clinical trial NCT03238703 · WITHDRAWN

Trial details

NCT number: NCT03238703
Sponsor: Fred Hutchinson Cancer Center
Status: WITHDRAWN
Phase: Phase 4
Study type: INTERVENTIONAL

HER2/Neu Negative Invasive Breast Carcinoma Postmenopausal Stage 0 Breast Cancer Stage IA Breast Cancer

Start date: 2018-09-01
Primary completion: 2023-03-14
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.